Bionomics has a lengthy history of successful alliances with industry and academia. In general, the company seeks to develop compounds to successful proof of concept in human clinical trials. We are open to expressions of interest with respect to partnership at all stages of development.

Additionally, Bionomics is open to in-licensing proposals that are in alignment with the company's overall therapeutic focus in cancer, inflammatory disorders and CNS diseases.


Bionomics is open to partnership interest in relation to the programs listed below. For more about each of these areas, follow the links provided.

  • BNC105

For any partnership interest, please contact Bionomics Business Development via our partnership contact page.